Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
European Journal of Case Reports in Internal Medicine
|
January 15, 2024
Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known?
Edmond Morrissey, Daniel Schmidt-Martin, Martin Buckley
The Journal of General Virology
|
April 17, 2015
Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection
Daniel Schmidt-Martin, Orla Crosbie, Elizabeth Kenny-Walsh, et al.
Journal of Virology
|
January 1, 2016
Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses
Brendan A Palmer, Daniel Schmidt-Martin, Zoya Dimitrova, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
European Journal of Case Reports in Internal Medicine
|
January 15, 2024
Treatment of Hereditary Haemorrhagic Telangiectasia with Bevacizumab - What More Needs to be Known?
Edmond Morrissey, Daniel Schmidt-Martin, Martin Buckley
The Journal of General Virology
|
April 17, 2015
Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection
Daniel Schmidt-Martin, Orla Crosbie, Elizabeth Kenny-Walsh, et al.
Journal of Virology
|
January 1, 2016
Network Analysis of the Chronic Hepatitis C Virome Defines Hypervariable Region 1 Evolutionary Phenotypes in the Context of Humoral Immune Responses
Brendan A Palmer, Daniel Schmidt-Martin, Zoya Dimitrova, et al.
JHEP Reports : Innovation in Hepatology
|
February 11, 2020
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, et al.
Page
of 1